TMS can detect abnormal synaptic plasticity associated with amyloid-beta and tau pathology in early staged dementia

Amyloid-beta (A β) and phosphorylated-Tau (pTau) proteins in cerebrospinal fluids (CSF) are known as the most reliable biomarker for early and preclinical staged Alzheimer’s disease (AD).

Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - January 22, 2019 Category: Neurology Authors: T. Murakami, M. Abe, A. Tiksnadi, N. Kobayashi, Y. Hashimoto, Y. Ugawa Source Type: research